Anna-Marie Roswold
Primary Care · The Villages, FLNPI 1205362332
Payments from drug & device makers
Across 77 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$129
- Boehringer Ingelheim$126
- Novo Nordisk$117
- AstraZeneca$88
- Pfizer$85
- Lilly USA, LLC$81
- plus $730 from 19 others
What the payments were for
- Food & beverage$1,355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $129 |
| Boehringer Ingelheim | 6 | $126 |
| Novo Nordisk | 7 | $117 |
| AstraZeneca(2 entities) | 6 | $88 |
| Pfizer | 5 | $85 |
| Lilly USA, LLC | 5 | $81 |
| Amarin Pharma, Inc. | 4 | $70 |
| Amgen | 4 | $69 |
| Sunovion Pharmaceuticals Inc. | 3 | $65 |
| Novartis | 4 | $65 |
| Eisai Inc. | 4 | $63 |
| Johnson & Johnson | 3 | $54 |
| Merck | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Abbott | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$1,355 in reported general payments places this provider in the 75th percentile of 725 primary care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 129 | $157,003 |
| EliquisApixaban | 43 | $58,689 |
| JardianceEmpagliflozin | 41 | $56,235 |
| MounjaroTirzepatide | 28 | $32,768 |
| Repatha SureclickEvolocumab | 30 | $27,984 |
| ProliaDenosumab | 11 | $19,995 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,797 |
| Famotidine | 105 | $2,989 |
| Omeprazole | 94 | $2,666 |
| Levothyroxine Sodium | 227 | $2,134 |
| Atorvastatin Calcium | 222 | $1,606 |
| Gabapentin | 60 | $1,343 |
| Duloxetine Hcl | 41 | $1,284 |
| Bupropion XlBupropion Hcl | 49 | $1,275 |
| Valsartan | 37 | $1,266 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $117 | $157,003129 claims |
| PfizerEliquis | $85 | $58,68943 claims |
| Boehringer IngelheimJardiance | $126 | $56,23541 claims |
| Lilly USA, LLCMounjaro | $81 | $32,76828 claims |
| AmgenProlia | $69 | $19,99511 claims |
| GSKBreo Ellipta | $20 | $9,79719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 725 primary care providers in Florida.
Other primary care in The Villages
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Maria Rodriguez ReyesHialeah$31K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.